The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

The government is hopeful the tariff threat to Big Pharma companies based here may have eased after what one minister ...

Clarity, along with most Aussie biotech, has been caught in a double whirlwind: a sharp sell-off in US healthcare stocks and ...